ADMA

ADMA Biologics, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$13.24

Price (1 Year)

$19.85 $7.97

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %6.3 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %3 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments.

Website

Analysis (Turkish): ADMA Hissesi Caiz mi, Helal mi? ADMA Biologics, Inc. Katılım Analizi